TransMedics Group, Inc.
TMDX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $605M | $442M | +37.1% |
| Operating income | $109M | $37.5M | +190% |
| Net income | $190M | $35.5M | +437% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $203M | $144M | +41.2% |
| Operating income | $28.1M | $23.3M | +20.6% |
| Net income | $17.1M | $24.3M | −29.6% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was TransMedics's revenue in FY2025?
- $605M in FY2025 (Fiscal year ended Dec 31, 2025), +37.1% vs $442M a year earlier, per its 10-K filed Feb 2026.
- Was TransMedics profitable in FY2025?
- Yes: net income was $190M and operating income $109M in FY2025.
- What was TransMedics's revenue in Q3 2026?
- $203M (+41.2% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.